J P Guastalla
- Oncology
- Radiology, Nuclear Medicine and Imaging
- Molecular Biology
- Genetics
- Pulmonary and Respiratory Medicine
- Co-authors
- Cyrille B. ConfavreuxF. MunozPierre D. DelmasA FontanaJohan G. BrunJ. B. VermorkenP. FumoleauM. Clavel
- Topics
- Cancer Treatment and Pharmacology (10 papers)Breast Cancer Treatment Studies (4 papers)Advanced Breast Cancer Therapies (3 papers)
- Partner nations
- FranceNetherlandsBelgium
In The Last Decade
J P Guastalla
14 papers receiving 304 citations
Peers
Comparison fields: 5 of 62
- Oncology 213
- Radiology, Nuclear Medicine and Imaging 84
- Molecular Biology 73
- Genetics 57
- Pulmonary and Respiratory Medicine 51
Countries citing papers authored by J P Guastalla
This map shows the geographic impact of J P Guastalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J P Guastalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J P Guastalla more than expected).
Fields of papers citing papers by J P Guastalla
This network shows the impact of papers produced by J P Guastalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J P Guastalla. The network helps show where J P Guastalla may publish in the future.
Co-authorship network of co-authors of J P Guastalla
This figure shows the co-authorship network connecting the top 25 collaborators of J P Guastalla. A scholar is included among the top collaborators of J P Guastalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J P Guastalla. J P Guastalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 24 | |
| 3 | 2 | |
| 4 | 45 | |
| 5 | 36 | |
| 6 | 11 | |
| 7 | 88 | |
| 8 | 1 | |
| 9 | A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma. | 45 |
| 10 | 21 | |
| 11 | Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study. | 8 |
| 12 | Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I study. | 8 |
| 13 | 9 | |
| 14 | [Chemotherapy of cancer of the breast in the metastatic phase]. | 1 |
About J P Guastalla
J P Guastalla is a scholar working on Oncology, Reproductive Medicine and Cancer Research, having authored 14 papers that have together received 312 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (4 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Oncology (213 citations), Orthopedics and Sports Medicine (47 citations) and Radiology, Nuclear Medicine and Imaging (84 citations). J P Guastalla has collaborated with scholars based in France, Netherlands and Belgium. Frequent co-authors include Cyrille B. Confavreux, F. Munoz, Pierre D. Delmas, A Fontana, Johan G. Brun, J. B. Vermorken, P. Fumoleau, M. Clavel, Hommo T. Edzes and Adrianus C. Laan. Their work appears in journals such as Cancer Research, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.